<![CDATA[Good medical journalism here getting out in front of an issue that's starting to get research attention: People feeling anhedonic on the GLP-1 meds.]]>Good medical journalism here getting out in front of an issue that's starting to get research attention: People feeling anhedonic on the GLP-1 meds. These meds seem to modify the dopamine system and any substance that does that should be handled with caution.

(Gift link)

https://wapo.st/4tgl0nu

]]>https://postcall.pub/topic/26e30d5a-d035-4efd-9092-b974e345a14c/good-medical-journalism-here-getting-out-in-front-of-an-issue-that-s-starting-to-get-research-attention-people-feeling-anhedonic-on-the-glp-1-meds.RSS for NodeThu, 30 Apr 2026 17:48:47 GMTFri, 17 Apr 2026 01:54:33 GMT60<![CDATA[Reply to Good medical journalism here getting out in front of an issue that's starting to get research attention: People feeling anhedonic on the GLP-1 meds. on Fri, 17 Apr 2026 02:01:35 GMT]]>@brianvastag Before GLP-1 came along, you could take a chrome supplement to suppress appetite. My short experience of that was that the whole world turns grey. There is no delight.

]]>https://postcall.pub/post/https://mastodon.social/users/LillyHerself/statuses/116417579962194366https://postcall.pub/post/https://mastodon.social/users/LillyHerself/statuses/116417579962194366Fri, 17 Apr 2026 02:01:35 GMT